Cargando…

Epidemiology and survival outcome of breast cancer in a nationwide study

Breast cancer is among the most prevalent cancers in Taiwan. The National Health Insurance database was used to identify patients with breast cancer and estimate the yearly prevalence and incidence of breast cancer between 1997 and 2013. Joinpoint regression analysis was used for the annual percenta...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fu-Chao, Lin, Huan-Tang, Kuo, Chang-Fu, See, Lai-Chu, Chiou, Meng-Jiun, Yu, Huang-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370012/
https://www.ncbi.nlm.nih.gov/pubmed/28199975
http://dx.doi.org/10.18632/oncotarget.15207
_version_ 1782518168547229696
author Liu, Fu-Chao
Lin, Huan-Tang
Kuo, Chang-Fu
See, Lai-Chu
Chiou, Meng-Jiun
Yu, Huang-Ping
author_facet Liu, Fu-Chao
Lin, Huan-Tang
Kuo, Chang-Fu
See, Lai-Chu
Chiou, Meng-Jiun
Yu, Huang-Ping
author_sort Liu, Fu-Chao
collection PubMed
description Breast cancer is among the most prevalent cancers in Taiwan. The National Health Insurance database was used to identify patients with breast cancer and estimate the yearly prevalence and incidence of breast cancer between 1997 and 2013. Joinpoint regression analysis was used for the annual percentage change of incidence, prevalence, and survival outcome. Among 12,181,919 female beneficiaries in 2013, the prevalence was 834.37 per 100,000 persons (95% confidence interval, 829.28–839.45) and the incidence was 93.00 per 100,000 person-year (95% confidence interval, 91.27–94.73). The average annual percentage change of the age-standardized breast cancer incidence was 3.5 per 100,000 person-years (3.1–3.8; P < 0.05), suggesting an increase in breast cancer incidence over the study period. The 5-year mortality rate was 4.5% in 1997 and 4.4% in 2008. The 5-year mortality rate among patients with Charlson comorbidity index > 1 was 39.1% (19.2%–59.1%) in 1997 and 21.1% (15.7%-32.0%) in 2008, with an annual percentage change of –0.8 (–1.3 to 2.9), suggesting that the mortality rate was gradually decreasing in patients with comorbidities. In conclusion, 1 in 120 women in Taiwan has breast cancer and the incidence is rising, while the annual percentage change of breast cancer prevalence is decreasing. The mortality rate of breast cancer was essentially stable, but the 1-year, 2-year, and 5-year mortality rates in people with Charlson comorbidity index > 1 were declined.
format Online
Article
Text
id pubmed-5370012
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53700122017-04-17 Epidemiology and survival outcome of breast cancer in a nationwide study Liu, Fu-Chao Lin, Huan-Tang Kuo, Chang-Fu See, Lai-Chu Chiou, Meng-Jiun Yu, Huang-Ping Oncotarget Research Paper Breast cancer is among the most prevalent cancers in Taiwan. The National Health Insurance database was used to identify patients with breast cancer and estimate the yearly prevalence and incidence of breast cancer between 1997 and 2013. Joinpoint regression analysis was used for the annual percentage change of incidence, prevalence, and survival outcome. Among 12,181,919 female beneficiaries in 2013, the prevalence was 834.37 per 100,000 persons (95% confidence interval, 829.28–839.45) and the incidence was 93.00 per 100,000 person-year (95% confidence interval, 91.27–94.73). The average annual percentage change of the age-standardized breast cancer incidence was 3.5 per 100,000 person-years (3.1–3.8; P < 0.05), suggesting an increase in breast cancer incidence over the study period. The 5-year mortality rate was 4.5% in 1997 and 4.4% in 2008. The 5-year mortality rate among patients with Charlson comorbidity index > 1 was 39.1% (19.2%–59.1%) in 1997 and 21.1% (15.7%-32.0%) in 2008, with an annual percentage change of –0.8 (–1.3 to 2.9), suggesting that the mortality rate was gradually decreasing in patients with comorbidities. In conclusion, 1 in 120 women in Taiwan has breast cancer and the incidence is rising, while the annual percentage change of breast cancer prevalence is decreasing. The mortality rate of breast cancer was essentially stable, but the 1-year, 2-year, and 5-year mortality rates in people with Charlson comorbidity index > 1 were declined. Impact Journals LLC 2017-02-09 /pmc/articles/PMC5370012/ /pubmed/28199975 http://dx.doi.org/10.18632/oncotarget.15207 Text en Copyright: © 2017 Liu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Liu, Fu-Chao
Lin, Huan-Tang
Kuo, Chang-Fu
See, Lai-Chu
Chiou, Meng-Jiun
Yu, Huang-Ping
Epidemiology and survival outcome of breast cancer in a nationwide study
title Epidemiology and survival outcome of breast cancer in a nationwide study
title_full Epidemiology and survival outcome of breast cancer in a nationwide study
title_fullStr Epidemiology and survival outcome of breast cancer in a nationwide study
title_full_unstemmed Epidemiology and survival outcome of breast cancer in a nationwide study
title_short Epidemiology and survival outcome of breast cancer in a nationwide study
title_sort epidemiology and survival outcome of breast cancer in a nationwide study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370012/
https://www.ncbi.nlm.nih.gov/pubmed/28199975
http://dx.doi.org/10.18632/oncotarget.15207
work_keys_str_mv AT liufuchao epidemiologyandsurvivaloutcomeofbreastcancerinanationwidestudy
AT linhuantang epidemiologyandsurvivaloutcomeofbreastcancerinanationwidestudy
AT kuochangfu epidemiologyandsurvivaloutcomeofbreastcancerinanationwidestudy
AT seelaichu epidemiologyandsurvivaloutcomeofbreastcancerinanationwidestudy
AT chioumengjiun epidemiologyandsurvivaloutcomeofbreastcancerinanationwidestudy
AT yuhuangping epidemiologyandsurvivaloutcomeofbreastcancerinanationwidestudy